The effect of ascorbic acid on plasma lipids and oxidisability of LDL in male smokers

European Journal of Clinical Nutrition

Volumn 51, Issue 7, 1997, Pages 472-477

  Samman, S ^a   Brown, A J ^b   Beltran, C ^a   Singh, S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b HEART RESEARCH INSTITUTE   (Australia)

Author keywords

Ascorbic acid; LDL oxidation; Lipids; Lipoproteins; Smokers

Indexed keywords

ASCORBIC ACID; COPPER; LIPID; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFECT; HUMAN; LIPID BLOOD LEVEL; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SMOKING; VENOUS BLOOD; VITAMIN BLOOD LEVEL;

EID: 0030747451     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600431     Document Type: Article

References (69)

1. Aro A, Kyllastinen M, Kostiainen E, Gref C-G, Elfving S & Uusitalo U (1988): No effect on serum lipids by moderate and high doses of vitamin C in elderly subjects with low plasma ascorbic acid levels. Ann. Nutr. Metab. 32, 133-137.
2. Aulinskas TH, Van der Westhuyzen DR & Coetzee GA (1983): Ascorbate increases the number of low density lipoprotein receptors in cultured arterial smooth muscle cells. Atherosclerosis 47, 159-171.
3. Bates CJ, Mandal AR & Cole TJ (1977): HDL cholesterol and vitamin-C status. Lancet 2, 611.
4. Bazzarre TL, Kleiner SM & Ainsworth BE (1992): Vitamin C intake and lipid profiles of competitive male and female bodybuilders. Int. J. Sports Nutr. 2, 260-271.
5. Belcher JD, Balla J, Balla G, Jacobs DR Jr, Gross M, Jacob HS & Vercellotti GM (1993): Vitamin E, LDL, and endothelium. Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arterioscl. Thromb. 13, 1779-1789.
6. Bolton-Smith C (1993): Antioxidant vitamin intakes in Scottish smokers and non-smokers. Ann. N. Y. Acad. Sci. 686, 347-358.
7. Brown AJ (1996): Acute effects of smoking cessation on antioxidant status. J. Nutr. Biochem. 7, 29-39.
8. Burr ML, Bates CJ, Goldberg G & Butland BK. (1985): Vitamin C and cholesterol in the elderly. Hum. Nutr: Clin. Nutr. 39C, 387-388.
9. Burr ML, Bates, CJ, Milbank JE & Yarnell JWG (1982): The relationship between plasma ascorbate and lipid concentrations in fasting men. Hum. Nutr: Clin. Nutr. 36C, 135-139.
10. Buzzard IM, McRoberts MR, Driscoll DL & Bowering J (1982): Effect of dietary eggs and ascorbic acid on plasma lipid and lipoprotein cholesterol level in healthy young men. Am. J. Clin. Nutr. 36, 94-105.
11. Cook NC & Samman S (1996): Flavonoids: chemistry, metabolism, cardioprotective effects and dietary sources. J. Nutr. Biochem. 7, 66-76.
12. Craig WY, Palomaki GE & Haddow JE (1989): Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br. Med. J. 298, 784-788.
13. Crawford GPM, Warlow CP, Bennett B, Dawson AA, Douglas AS, Kerridge DF & Ogston D (1975): The effect of vitamin C supplements on serum cholesterol, coagulation, fibrinolysis and platelet adhesiveness. Atherosclerosis 21, 451-454.
14. Cross CE & Halliwell B (1993): Nutrition and human disease: how much extra vitamin C might smokers need? Lancet 341, 1091.
15. Dallai GE, Choi E, Jacques P, Schaefer EJ & Jacob RA (1989): Ascorbic acid, HDL cholesterol and apolipoprotein A-I in an elderly Chinese population in Boston. J. Am. Coll. Nutr. 8, 69-74.
16. Duthie GG, Arthur JR, Beattie JAG, Brown KM, Morrice PC, Robertson JD, Short CT, Walker KA & James WPT (1993): Cigarette smoking, antioxidants, lipid peroxidation, and coronary heart disease. Ann. N. Y. Acad. Sci 686, 120-129.
17. Elwood PC, Hughes RE & Hurley RJ (1970): Ascorbic acid and serum cholesterol. Lancet 2, 1197.
18. Esterbauer H, Striegl G, Puhl H & Rotheneder M (1989): Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Comm. 6, 67-75.
19. Esterbauer H, Dieber-Rotheneder M, Striegl G & Waeg G (1991): Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am. J. Clin. Nutr. 53, 314S-321S.
20. Fidanza A, Audisio M & Mastroiacovo P (1982): Vitamin C and cholesterol. Int. J. Vit. Nutr. Res. 23, 153-171.
21. Frei B, Forte TM, Ames BN & Cross CE (1991): Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid. Biochem. J. 277, 133-138.
22. Fuller CJ, Grundy SM, Norkus EP & Jialal I (1995): Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers. Atherosclerosis 119, 139-150.
23. Gale CR, Martyn CN, Winter PD & Cooper C (1985): Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. Br. Med. J. 310, 1563-1566.
24. Gatto LM & Samman S (1995): The effect of zinc supplementation on plasma lipids and LDL oxidation in males. Free Rad. Biol. Med. 19, 517-521.
25. Gatto LM, Hallen GK, Brown AJ & Samman S (1996): Ascorbic acid supplementation produces a favourable lipoprotein profile in healthy young women. J. Am. Coll. Nutr. 15, 154-158.
26. Gershoff SN (1993): Vitamin C (Ascorbic acid): New roles, new requirements? Nutr. Rev. 51, 313-326.
27. Gey KF (1995): Ten-year retrospective on the antioxidant hypothesis of arteriosclerosis: Threshold plasma levels of antioxidant micronutrients related to minimum cardiovascular risk. J. Nutr. Biochem. 6, 206-236.
28. Ginter E (1979): Pretreatment serum-cholesterol and response to ascorbic acid. Lancet 2, 958-959.
29. Greco AM & La Rocca L (1982): Correlation between chronic hypovitaminosis C in old age and plasma levels of cholesterol and triglycerides. Int. J. Vit. Nutr. Res. 23, 129-136.
30. Hallen GK, Ahmad ZI & Samman S (1994): The impact of micronutrient interactions on antioxidant status in healthy subjects: Ascorbic acid and copper. Proc. Nutr. Soc. Aust. 18, 86.
31. 2 cholesterol. Am. J. Clin. Nutr. 60, 100-105.
32. Harats D, Ben-Naim M, Dabach Y, Hollander G, Havivi E, Stein O & Stein Y (1990): Effect of vitamin C and E supplementation on the susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis 85, 47-54.
33. Hemila H (1992): Vitamin C and plasma cholesterol. Crit. Rev. Food Sci. Nutr. 32, 33-57.
34. Herbert V (1993): Does Mega-C do more good than harm, or more harm than good? Nutr. Today 1, 28-32.
35. Holloway DE, Peterson FJ, Prigge WF & Gebhard RL (1981): Influence of dietary ascorbic acid upon enzymes of sterol biosynthesis in guinea pigs. Biochem. Biophys. Res. Comm. 102, 1283-1289.
36. Horio F, Ikeda S & Yoshida A (1993): L-Ascorbic acid regulates the expression of apolipoprotein A-I gene in scurvy-prone ODS rats. XV Int. Cong. Nutr. Adelaide, Int. Union Nutr. Sci. 2, 781.
37. Itoh R, Yamada K, Oka J, Echizen H, Suyama Y & Murakami K (1990): Serum ascorbic acid and HDL cholesterol in a healthy elderly Japanese population. Int. J. Vit. Nutr. Res. 60, 360-365.
38. Jacques PF (1992): Effect of vitamin C on high-density lipoprotein cholesterol and blood pressure. J. Am. Coll. Nutr. 11, 139-144.
39. Jacques PF, Sulsky SI, Perrone GA & Schaefer EJ (1994): Ascorbic acid and plasma lipids. Epidemiology 5, 19-26.
40. Jialal I, Vega GL & Grundy S (1990): Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis 82, 185-191.
41. Johnson GE & Obenshain SS (1981): Nonresponsiveness of serum high-density lipoprotein-cholesterol to high dose ascorbic acid administration in normal men. Am. J. Clin. Nutr. 34, 2088-2091.
42. Khan AR & Seedarnee FA (1981): Effect of ascorbic acid on plasma lipids and lipoproteins in healthy young women. Atherosclerosis 39, 89-95.
43. Khaw K-T & Woodhouse P (1995): Interrelation of Vitamin C, infection, hemostatic factors, and cardiovascular disease. Br. Med. J. 310, 1559-1563.
44. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y & Bostick RM (1996): Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N. Engl. J. Med. 334, 1156-1162.
45. Lepage G & Roy GC (1986): Direct transesterification of all classes of lipid in a one-step reaction. J. Lipid Res. 27, 114-120.
46. Lux O & Naidoo D (1994): Biological variation of ascorbic acid and α-tocopherol. Redox. Report 1, 45-49.
47. Markwell MA, Haas SM, Bieber LL & Tolbert NE (1978): A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Analyt. Biochem. 87, 206-210.
48. Menne IV, Grey PC, Kotze JP, Sommers DK, Brown JMM & Spies JH (1975): Ascorbic acid and blood lipid and uric acid levels of students. S. Afr. Med. J. 49, 2225-2228.
49. Mezzetti A, Lapenna D, Pierdomenico SD, Calafiore AM, Costantini F, Riario-Sforza G, Imbastaro T, Neri M & Cuccurullo F (1995): Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers. Artherosclerosis 112, 91-99.
50. Ness AR, Khaw KT, Bingham S & Day NE (1996): Vitamin C and serum lipids. Ear. J. Clin. Nutr. 50, 724-729.
51. Peterson VE, Crapo PA, Weininger J, Ginsberg H & Olefsky J (1995): Quantification of plasma cholesterol and triglyceride levels in hypercholesterolaemic subjects receiving ascorbic acid supplements. Am. J. Clin. Nutr. 28, 584-587.
52. Read RDS (1990): Vitamin C. In Recommended Nutrient Intakes eds. AS Truswell, IE Dreosti, R English, IHE Rutishauser, N Palmer, pp 122-148. Australian papers. Australian Professional Publications: Mosman, NSW.
53. Retsky KL, Freeman MW & Frei B (1993): Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti-rather than prooxidant activity of vitamin C in the presence of transition metal ions. J. Biol Chem. 268, 1304-1309.
54. Rifici VA & Khachadurian AK (1993): Dietary supplementation with vitamins C and E inhibits in vitro oxidation of lipoprotems. J. Am. Coll. Nutr. 12, 631-637.
55. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA & Willett WC (1993): Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328, 1450-1456.
56. Salonen JT, Salonen R, Seppanen K, Kantola M, Parviamen M, Alfthan G, Maenpaa PH, Taskinen E & Rauramaa R (1988): Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men. Atherosclerosis 70, 155-160.
57. Samman S (1991): Nutritional considerations in the variability of plasma cholesterol measurements. Eur. J. Clin. Nutr. 45, 463-468.
58. Samman S & Truswell AS (1993): The Friedewald equation for the determination of low-density lipoprotein cholesterol: a special case. Am. J. Clin. Nutr. 58, 928-929.
59. Samman S, Lyons-Wall PM, Cook NC & Naghii MR (1996): Minor dietary factors in relation to coronary heart disease - flavonoids, isoflavones and boron. J. Clin. Biochem. Nutr. 20, 173-180.
60. Samuel P & Shalchi OB (1964): Effect of vitamin C on serum cholesterol in patients with hypercholesterolaemia and atherosclerosis. Circulation 29, 24-25.
61. Sato K, Niki E & Shimasaki H (1990): Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Arch Biochem. Biophys. 279, 402-405.
62. Schectman G (1993): Estimating ascorbic acid requirements for cigarette smokers. Ann. N.Y. Acad. Sci. 686, 335-347.
63. Simon JA, Schreiber GB, Crawford PB, Frederick MM & Sabry ZI (1993): Dietary vitamin C and serum lipids in black and white girls. Epidemiology 4, 537-542.
64. Spittle CR (1971): Atherosclerosis and vitamin C. Lancet 2, 1280-1281.
65. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B & Willett WC (1993): Vitamin E consumption and the risk of coronary heart disease in women. N. Engl. J. Med. 328, 1444-1449.
66. Steinberg D, Parthasarathy S, Carew TE, Khoo JC & Witztum JD (1989): Beyond cholesterol: modifications of low density lipoprotein that increases its atherogenicity. N. Engl. J. Med. 320, 915-924.
67. van den Berg GJ, van Wouwe JP & Beynen AC (1990): Ascorbic acid supplementation and copper status in rats. Biol. Trace Elem. Res. 23, 165-172.
68. Wahlberg G & Walldius G (1982): Lack of effect of ascorbic acid on serum lipoprotein concentrations in patients with hypertriglyceridaemia. Atherosclerosis 43, 283-288.
69. 2 precipitation procedure for quantisation of high-density-lipoprotein cholesterol. Clin. Chem. 28, 1379-1388.